Correction to “A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy”
Source abstract
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to "A Visible Codelivery Nanovaccine of Antigen and Adjuvant with Self-Carrier for Cancer Immunotherapy"Xia DongXia DongMore by Xia Dong, Jie LiangJie LiangMore by Jie Liang, Afeng YangAfeng YangMore by Afeng Yang, Zhiyong QianZhiyong QianMore by Zhiyong Qianhttps://orcid.org/0000-0003-2992-6424, Deling KongDeling KongMore by Deling Konghttps://orcid.org/0000-0002-5520-0769, and Feng Lv*Feng LvMore by Feng Lvhttps://orcid.org/0000-0002-0583-1810Cite this: ACS Appl. Mater. Interfaces 2022, 14, 3, 4808–4809Publication Date (Web):January 14, 2022Publication History Published online14 January 2022Published inissue 26 January 2022https://pubs.acs.org/doi/10.1021/acsami.1c25198https://doi.org/10.1021/acsami.1c25198correctionACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views639Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (2 MB) Get e-Alertsclose Get e-Alerts
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.